International Clinical Trial: A Randomized, Prospective, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intrarterial Injection of Recombinant TNK Tissue Plasminogen Activator (TNK) Following Partial Reperfusion (eTICI 2b50/67) in Mechanical Thrombectomy for Acute Large Vessel Occlusion

Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117118) titled 'A Randomized, Prospective, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Intrarterial Injection of Recombinant TNK Tissue Plasminogen Activator (TNK) Following Partial Reperfusion (eTICI 2b50/67) in Mechanical Thrombectomy for Acute Large Vessel Occlusion' on Jan. 20.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Shenzhen Hospital of Southern Medical Unversity

Condition: Acute Large Vessel Occlusion Stroke

Intervention: TNK group:Patients with large vessel occlusion stroke and eTICI score of 2b50/67 after mechanical thrombectomy receive...